Fludrocortisone Acetate
Cortineff belongs to a group of medications called steroids (full name: mineralocorticosteroids).
These are hormones produced in the body by the adrenal cortex.
They have a strong effect on the metabolism of salts and minerals in the body.
They are also responsible for the distribution of water (fluids) in the body.
Cortineff contains a synthetic (artificial) hormone of the adrenal cortex.
Cortineff is indicated for use in the treatment of:
Before starting Cortineff, discuss it with your doctor or pharmacist.
During treatment with Cortineff, some patients may experience:
Before taking Cortineff, inform your doctor if you have:
During treatment with Cortineff, your doctor may recommend a blood test (monitoring of salt uptake and electrolyte levels in serum).
Inform your doctor about all medications you are currently taking or have recently taken, including those available without a prescription.
Certain medications may enhance the effect of Cortineff, and your doctor may want to closely monitor your condition while taking such medications (including certain HIV medications: ritonavir, cobicistat).
If you experience blurred vision or other vision disturbances, contact your doctor.
During treatment with this medication, follow your doctor's instructions carefully.
Regular medical check-ups are necessary. Cortineff may cause growth and development disorders in infants and children (especially if the medication is used for a long time).
Inform your doctor or pharmacist about all medications you are currently taking or plan to take.
You should inform your doctor if you are taking any of the following medications:
Cortineff should be taken between meals.
This medication increases sodium retention in the body, which may cause edema and increased blood pressure. Therefore, you should limit your salt intake in food.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor before taking Cortineff.
Cortineff should not be used in pregnant women.
Small amounts of the medication pass into breast milk. You should consider whether to stop breastfeeding or not to breastfeed due to the need for treatment.
There is no data on the effect of fludrocortisone on the ability to drive and use machines.
One tablet contains 57.90 mg of lactose monohydrate (a type of sugar). If you have been diagnosed with intolerance to some sugars, consult your doctor before taking the medication.
This medication should always be taken as directed by your doctor. In case of doubts, consult your doctor or pharmacist.
The dose of Cortineff and the duration of treatment are determined by your doctor.
Recommended dose:
1 to 3 tablets (from 100 micrograms to 300 micrograms) per day
or
2 to 3 tablets (from 200 micrograms to 300 micrograms) every other or every third day.
Tablets should not be divided.
The medication should be taken orally .
In case of taking a higher dose than recommended, stop taking the medication and consult your doctor immediately.
If you miss a dose, take the medication as soon as possible. If it is almost time for the next dose, skip the missed dose.
Do not take a double dose to make up for the missed dose.
Stopping treatment with Cortineff is decided by your doctor.
Stopping treatment after long-term use of the medication may lead to acute adrenal insufficiency, decreased blood pressure, and death.
The following symptoms of glucocorticosteroid withdrawal syndrome may occur:
fever, muscle and joint pain, malaise, runny nose, conjunctivitis, itching hives, and weight loss.
In case of any further doubts about the use of this medication, consult your doctor or pharmacist.
Like all medications, Cortineff can cause side effects, although not everybody gets them.
Consult your doctor immediatelyif you experience any of the following symptoms:
The risk of side effects listed below is mainly related to patients receiving Cortineff for a long time or in combination with other corticosteroids.
Frequency not known:
If you experience any side effects, including those not listed in this leaflet, inform your doctor or pharmacist, or nurse.
Side effects can be reported directly to the Department of Post-Marketing Surveillance of Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medication.
Keep the medication out of sight and reach of children.
Store in a temperature below 25°C.
Store in the original packaging to protect from light and moisture.
Do not use this medication after the expiry date stated on the label and carton after "Expiry Date".
The expiry date stated is the last day of the month.
Medications should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medications that are no longer needed. This will help protect the environment.
The active substance of Cortineff is fludrocortisone acetate.
One tablet contains 100 micrograms of fludrocortisone acetate.
The other ingredients are: lactose monohydrate, potato starch, gelatin, magnesium stearate.
Cortineff tablets are white with a creamy tint, round, flat on both sides, with a smooth surface. They are engraved on both sides: with the letter "F" on one side and a "-" sign on the other.
The packaging contains 20 tablets in a brown glass bottle with a polyethylene cap or 20 tablets in a PVC/Al blister.
Adamed Pharma S.A.
Pieńków, ul. M. Adamkiewicza 6A
05-152 Czosnów
Adamed Pharma S.A.
Pieńków, ul. M. Adamkiewicza 6A
05-152 Czosnów
Date of last revision of the leaflet:03.2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.